Evidence map›Paper›PMID 34554814›Full record

Trial reportJCO global oncology2021

Impact of Mobile Technologies on Cervical Cancer Screening Practices in Lagos, Nigeria (mHealth-Cervix): A Randomized Controlled Trial.

Kehinde S Okunade, Adaiah Soibi-Harry, Sarah John-Olabode, Adebola A Adejimi, Matthew J Allsop, Tonia C Onyeka, Godwin O Akaba, Yusuf A Oshodi, Omolola Salako, Aloy O Ugwu and 3 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in JCO global oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Impact of the COVID-19 Pandemic on Cancer Screening Delays.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 3 countries.

Kehinde S OkunadeDepartment of Obstetrics and Gynaecology, College of Medicine, University of Lagos, Surulere, Lagos, Nigeria.ORCID 0000-0002-0957-7389
Adaiah Soibi-HarryDepartment of Obstetrics and Gynaecology, Lagos University Teaching Hospital, Surulere, Lagos, Nigeria.ORCID 0000-0001-5938-3235
Sarah John-OlabodeDepartment of Haematology and Blood Transfusion, College of Medicine, University of Lagos, Surulere, Lagos, Nigeria.ORCID 0000-0001-7130-9812
Adebola A AdejimiDepartment of Community Health and Primary Care, College of Medicine, University of Lagos, Surulere, Lagos, Nigeria.ORCID 0000-0003-3535-7344
Matthew J AllsopAcademic Unit of Palliative Care, Leeds Institute of Health Sciences, University of Leeds, Leeds, United Kingdom.ORCID 0000-0002-7399-0194
Tonia C OnyekaDepartment of Anaesthesia, College of Medicine, University of Nigeria, Enugu, Enugu State, Nigeria.ORCID 0000-0001-8138-3100
Godwin O AkabaDepartment of Obstetrics and Gynaecology, College of Health Sciences, University of Abuja, Gwadalada, Abuja FCT, Nigeria.ORCID 0000-0002-8149-5492
Yusuf A OshodiDepartment of Obstetrics and Gynaecology, Lagos State University College of Medicine, Ikeja, Lagos, Nigeria.ORCID 0000-0001-5501-2891
Omolola SalakoDepartment of Radiation Biology, Radiotherapy, Radio-diagnosis and Radiography, College of Medicine, University of Lagos, Surulere, Lagos, Nigeria.ORCID 0000-0003-3165-8879
Aloy O UgwuDepartment of Obstetrics and Gynaecology, Lagos University Teaching Hospital, Surulere, Lagos, Nigeria.ORCID 0000-0003-2405-9720
Ayodeji AdefemiDepartment of Obstetrics and Gynaecology, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.
Rose I AnorluDepartment of Obstetrics and Gynaecology, College of Medicine, University of Lagos, Surulere, Lagos, Nigeria.
Jonathan S BerekDepartment of Obstetrics and Gynaecology, Stanford University School of Medicine, Stanford, CA.
University of Lagos · NGLagos University Teaching Hospital · NGLagos State University · NGLagos State University Teaching Hospital · NGStanford University · USUniversity of Abuja · NGUniversity of Leeds · GBUniversity of Nigeria · NG

Funding

Neuro HPA Project 1U54AG062334 · NIA · EMORY UNIVERSITY · PI Ighovwerha Ofotokun · 2018 to 2026
$12.2M
Partnership for Global Health Research Training Program (Renewal)-Supplement for OBSSR, NCI, NCI-AIDS and NIDCDD43TW010543 · FIC · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Wafaie W Fawzi, DAVIDSON HOWES HAMER · 2017 to 2026
$12.1M
Building Research And Innovation in Nigeria's Science - (BRAINS)D43TW010134 · FIC · COLLEGE OF MEDICINE, UNIVERSITY OF LAGOS · PI OGUNSOLA, FOLASADE TOLULOPE · 2015 to 2020
$3.2M
Nigeria HIV Research Training ProgramD43TW010934 · FIC · EMORY UNIVERSITY · PI Ighovwerha Ofotokun · 2019 to 2026
$2.4M
FIC NIH HHS D43 TW010134FIC NIH HHS D43 TW010543FIC NIH HHS D43 TW010934NIA NIH HHS U54 AG062334
6 · The paper itself

Abstract

purposeWe assessed the impact of mHealth on Pap test screening uptake and also determined the factors that affect screening uptake among women in Lagos, Nigeria. MATERIALS AND

methodsA randomized controlled trial was carried out among women in two tertiary health institutions in Lagos, Nigeria, between July 2020 and March 2021. Participants were randomly assigned to either a text message (mHealth) intervention or usual care arm. The main study outcome was the uptake of Pap smear testing within 6 months of enrollment in the study. We tested the associations between two groups of continuous variables using the unpooled independent-sample

resultsThere was a significantly higher rate of uptake of Pap smear screening among women in the mHealth arm compared with those in the usual care arm (51.0%

conclusionThe use of mHealth technologies intervention via short-text message services is a feasible solution for cervical cancer prevention in low- and middle-income countries, and thus, the widespread use of mHealth services by health care providers and policymakers could contribute to the implementation of cervical cancer prevention services in Nigeria and in the settings of other low- and middle-income countries.

Indexed as

TelemedicineUterine Cervical NeoplasmsEarly Detection of CancerFemaleHumansNigeria

Identifiers

PMID34554814
PMCPMC8478387
OpenAlexW3199424375

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.